期刊文献+

唑来膦酸对大鼠成骨细胞增殖、分化和矿化功能的影响 被引量:3

Influence of Zoledronic Acid on the Proliferation,Differentiation and Mineralizaton of Rat Osteoblast
下载PDF
导出
摘要 目的:观察唑来膦酸对大鼠成骨细胞生物学功能的影响。方法:体外培养的新生大鼠颅盖骨来源的成骨细胞,观察不同浓度(10-4M^10-11M)唑来膦酸对细胞增殖、碱性磷酸酶(ALP)活性和矿化结节形成的影响。结果:唑来磷酸浓度≥10-5M时抑制细胞增殖,10-6M^10-11M则不影响细胞增殖;10-7M^10-11M对ALP活性没有影响,10-7M对矿化小结形成有抑制作用,10-11M则促进矿化功能。结论:唑来磷酸在低浓度时不影响骨形成,选择恰当的剂量和给药方案可助于发挥双磷酸盐抑制破骨作用的同时促进骨形成。 Objective: To study the effects on the biological function of rat osteoblasts. Methods: We examined the direct actions of different concentration zoledronic acid on the proliferation, differentiation and mineralization of cultured osteoblasts derived from rat calvariae. Results: Zoledronic acid inhibited prolifera- tion of osteoblast at concentration of 10^-5M and greater, had no effect on proliferation of osteoblast at concentation between 10^-6M to 10^-11 M. We found no effect of the zoledronic acid on alkaline phosphatase activity at 10^-7M- 10^-11 M concentrations and mineralized bone nodules formation at concentration of 10^-9M, but zoledronic acid inhibited mineralized bone nodules formation at concentration of 10^-7 M, promoted mineralization at concentration of 10^-11M. Conclusion: There is no effect on bone forming of zoledronic acid at lower concentrations. Pertinent dose and dosing regimens route of can benefit not only inhibition of osteoclast but also promoting bone formation.
出处 《数理医药学杂志》 2009年第3期267-271,共5页 Journal of Mathematical Medicine
关键词 唑来瞵酸 成骨细胞 增殖 分化 矿化 zoledronic acid osteoblast proliferation differentiation mineralization
  • 相关文献

参考文献13

  • 1Rogers MJ,Benfo rd HL,Coxon JP,et al.Cellular and mo lecularmechanism s of action of bispho sphonates.Cancer,2000,88 (12Supp l):2961-2978.
  • 2Orriss IR,Key ML,Colston KW,et al.Inhibition of osteoblast function in vitro by aminobisphosphonates.J Cell Biochem,2009,106(1):109-118.
  • 3Pan B,To LB,Farrugia AN,et al.The nitrogen-containing bisphosphonate,zoledronic acid,increases mineralisation of human bonederived cells in vitro.Bone,2004,34(1):112-123.
  • 4Skoglund B,Holmertz J,AspenbergP.Systemic and local ibandronate enhance screw fixation.J Orthop Res,2004,22:1108-1113.
  • 5Peter B,Pioletti DP,Laib S,et al.Calcium phosphate drug delivery system:influence of local zoledronate release on bone implant osteointegration.Bone,2005,36(1):52-60.
  • 6Soininvaara TA,Jurvelin JS,Miettinen HJ,et al.Effect of alendronate on periprosthetic bone loss after total knee arthroplasty:a one-year,randomized,controlled trial of 19 patients.Calcif Tissue Int,2002,71(6):472-477.
  • 7Agarwala S,Jain D,Joshi VR,et al.Efficacy of alendronate,a bisphosphonate,in the treatment of AVN of the hip.A prospective open-label study.Rheumatology (Oxford),2005,44(3):352-359.
  • 8Nishii T,Sugano N,Miki H,et al.Does Alendronate Prevent Collapse in Osteonecrosis of the Femoral Head? Clin Orthop Relat Res,2006,443:273-279.
  • 9Lai KA,Shen WJ,Yang CY,et al.The Use of Alendronate to Prevent Early Collapse of the Femoral Head in Patients with Nontraumatic Osteonecrosis.A Randomized Clinical Study.J Bone Joint Surg Am,2005,87(10):2155-2159.
  • 10Recker RR,Delmas PD,Halse J,et al.Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.J Bone Miner Res,2008,23(1):6-16.

同被引文献35

  • 1蒋四清,李锋,李光辉,陈安民.阿仑膦酸钠对大鼠成骨细胞增殖的影响[J].中国矫形外科杂志,2005,13(12):918-920. 被引量:6
  • 2李湘辉,陆志坚,张金超,陈瑶,隋森芳,杨梦甦.阿伦磷酸钠对小鼠骨髓基质细胞成骨和成脂分化的影响[J].中国药理学通报,2006,22(6):671-674. 被引量:14
  • 3苏钟毅,尹芸生,李栋,胡宏亮,刘巍,郝东升.胰岛素样生长因子-Ⅰ促骨质疏松骨折愈合的实验研究[J].中国药物与临床,2007,7(3):182-185. 被引量:14
  • 4Im GI,Qurreshi SA,Kenney J,et al.Osteoblast proliferation and maturation by bisphosphonates[J].Biomaterials,2004,25(18):4105-4115.
  • 5Russell RG.Bisphosphonates:from bench to bedside[J].Ann NY Acad Sci,2006,1068:367-401.
  • 6Rogers MJ,Gordon S,Benford HI,et al.Cellular and molecular mech-anisms of action of bi sphosphonates[J].Cancer,2000,88(Suppl 12):2961-2978.
  • 7Schmid C,Guler HP,Rowe D,et al.Insulin-like growth factor 1 regulates type 1 procollagen messenger ribonucleic acid steady state levels in bone of rats[J].Endocrinology,1989,125(3):1575-1580.
  • 8Miyakoshi N,0in X,Kasukawa Y,et al.Systemic administration of insulinlike growth factor (1GF-1)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism[J].Endocrinology,2001,142(6):2641.
  • 9Hock JM,Centrells M,Canalis E,et al.Insulin-like growth factor 1 has independent effects on bone matrix formation and cell replaction[J].Endocrinology,1988,122(1):254.
  • 10Pan B,To LB,Farrugia AN,et al.The nitrogen-containing bisphosphonate,Zoledronic acid,increases mineralisation of human bone-derived cells in vitro[J].Bone,2004,34(1):112-123.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部